A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor | Synapse
March 26, 2020Open Access
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
Key Points
Key points are not available for this paper at this time.
Abstract
clinicaltrials.gov: NCT03069989; date of registration: 3 March 2017.